Trebst C - Search Results

1

Longitudinal extensive transverse myelitis--it's not all neuromyelitis optica.

Trebst C, Raab P, Voss EV, Rommer P, Abu-Mugheisib M, Zettl UK, Stangel M. Trebst C, et al. Nat Rev Neurol. 2011 Nov 1;7(12):688-98. doi: 10.1038/nrneurol.2011.176. Nat Rev Neurol. 2011. PMID: 22045269 Review.

2

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica.

Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, Trebst C, Weinshenker B, Wingerchuk D, Parisi JE, Lassmann H. Lucchinetti CF, et al. Among authors: trebst c. Brain. 2002 Jul;125(Pt 7):1450-61. doi: 10.1093/brain/awf151. Brain. 2002. PMID: 12076996 Free PMC article.

3

Remyelination strategies: new advancements toward a regenerative treatment in multiple sclerosis.

Stangel M, Trebst C. Stangel M, et al. Among authors: trebst c. Curr Neurol Neurosci Rep. 2006 May;6(3):229-35. doi: 10.1007/s11910-006-0010-2. Curr Neurol Neurosci Rep. 2006. PMID: 16635432 Review.

4

Lack of interferon-beta leads to accelerated remyelination in a toxic model of central nervous system demyelination.

Trebst C, Heine S, Lienenklaus S, Lindner M, Baumgärtner W, Weiss S, Stangel M. Trebst C, et al. Acta Neuropathol. 2007 Dec;114(6):587-96. doi: 10.1007/s00401-007-0300-z. Epub 2007 Oct 17. Acta Neuropathol. 2007. PMID: 17940777

5

Effects of interferon-beta on co-signaling molecules: upregulation of CD40, CD86 and PD-L2 on monocytes in relation to clinical response to interferon-beta treatment in patients with multiple sclerosis.

Wiesemann E, Deb M, Trebst C, Hemmer B, Stangel M, Windhagen A. Wiesemann E, et al. Among authors: trebst c. Mult Scler. 2008 Mar;14(2):166-76. doi: 10.1177/1352458507081342. Epub 2007 Oct 17. Mult Scler. 2008. PMID: 17942524 Clinical Trial.

6

Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent.

Skripuletz T, Lindner M, Kotsiari A, Garde N, Fokuhl J, Linsmeier F, Trebst C, Stangel M. Skripuletz T, et al. Among authors: trebst c. Am J Pathol. 2008 Apr;172(4):1053-61. doi: 10.2353/ajpath.2008.070850. Epub 2008 Mar 18. Am J Pathol. 2008. PMID: 18349131 Free PMC article.

7

The chemokine receptor CXCR2 is differentially regulated on glial cells in vivo but is not required for successful remyelination after cuprizone-induced demyelination.

Lindner M, Trebst C, Heine S, Skripuletz T, Koutsoudaki PN, Stangel M. Lindner M, et al. Among authors: trebst c. Glia. 2008 Aug 1;56(10):1104-13. doi: 10.1002/glia.20682. Glia. 2008. PMID: 18442092

8

Demyelination of the hippocampus is prominent in the cuprizone model.

Koutsoudaki PN, Skripuletz T, Gudi V, Moharregh-Khiabani D, Hildebrandt H, Trebst C, Stangel M. Koutsoudaki PN, et al. Among authors: trebst c. Neurosci Lett. 2009 Feb 13;451(1):83-8. doi: 10.1016/j.neulet.2008.11.058. Epub 2008 Dec 3. Neurosci Lett. 2009. PMID: 19084049

9

Chronic toxic demyelination in the central nervous system leads to axonal damage despite remyelination.

Lindner M, Fokuhl J, Linsmeier F, Trebst C, Stangel M. Lindner M, et al. Among authors: trebst c. Neurosci Lett. 2009 Apr 3;453(2):120-5. doi: 10.1016/j.neulet.2009.02.004. Epub 2009 Feb 10. Neurosci Lett. 2009. PMID: 19356606

10

Plasma exchange therapy in steroid-unresponsive relapses in patients with multiple sclerosis.

Trebst C, Reising A, Kielstein JT, Hafer C, Stangel M. Trebst C, et al. Blood Purif. 2009;28(2):108-15. doi: 10.1159/000224630. Epub 2009 Jun 11. Blood Purif. 2009. PMID: 19521072

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

137 results

Search Page

Filters